Baseline Characteristics of Randomized Participants Receiving Study Vaccine
| Characteristic . | MR + HRV (n = 240) . | MR (n = 240) . |
|---|---|---|
| Male sex | 130 (54.2) | 117 (48.8) |
| Age, mo | 9.4 ± 0.25 | 9.4 ± 0.25 |
| Ever breastfed | 240 (100.0) | 240 (100.0) |
| Length, cm | 69.6 ± 2.49 | 69.8 ± 2.79 |
| Weight, kg | 8.0 ± 1.10 | 8.0 ± 0.99 |
| Mother's age, y | 28.1 ± 5.66 | 28.0 ± 6.06 |
| Characteristic . | MR + HRV (n = 240) . | MR (n = 240) . |
|---|---|---|
| Male sex | 130 (54.2) | 117 (48.8) |
| Age, mo | 9.4 ± 0.25 | 9.4 ± 0.25 |
| Ever breastfed | 240 (100.0) | 240 (100.0) |
| Length, cm | 69.6 ± 2.49 | 69.8 ± 2.79 |
| Weight, kg | 8.0 ± 1.10 | 8.0 ± 0.99 |
| Mother's age, y | 28.1 ± 5.66 | 28.0 ± 6.06 |
Data are no. (%) of children or mean value ± SD.
Abbreviations: HRV, human rotavirus vaccine; MR, measles-rubella vaccine.
Baseline Characteristics of Randomized Participants Receiving Study Vaccine
| Characteristic . | MR + HRV (n = 240) . | MR (n = 240) . |
|---|---|---|
| Male sex | 130 (54.2) | 117 (48.8) |
| Age, mo | 9.4 ± 0.25 | 9.4 ± 0.25 |
| Ever breastfed | 240 (100.0) | 240 (100.0) |
| Length, cm | 69.6 ± 2.49 | 69.8 ± 2.79 |
| Weight, kg | 8.0 ± 1.10 | 8.0 ± 0.99 |
| Mother's age, y | 28.1 ± 5.66 | 28.0 ± 6.06 |
| Characteristic . | MR + HRV (n = 240) . | MR (n = 240) . |
|---|---|---|
| Male sex | 130 (54.2) | 117 (48.8) |
| Age, mo | 9.4 ± 0.25 | 9.4 ± 0.25 |
| Ever breastfed | 240 (100.0) | 240 (100.0) |
| Length, cm | 69.6 ± 2.49 | 69.8 ± 2.79 |
| Weight, kg | 8.0 ± 1.10 | 8.0 ± 0.99 |
| Mother's age, y | 28.1 ± 5.66 | 28.0 ± 6.06 |
Data are no. (%) of children or mean value ± SD.
Abbreviations: HRV, human rotavirus vaccine; MR, measles-rubella vaccine.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
